Greece · Delayed Price · Currency is EUR Biokarpet Statistics
Total Valuation
Biokarpet has a market cap or net worth of EUR 40.30 million. The enterprise value is 154.70 million.
| Market Cap | 40.30M |
| Enterprise Value | 154.70M |
Important Dates
The next confirmed earnings date is Friday, September 25, 2026.
| Earnings Date | Sep 25, 2026 |
| Ex-Dividend Date | Aug 24, 2026 |
Share Statistics
Biokarpet has 23.99 million shares outstanding.
| Current Share Class | 23.99M |
| Shares Outstanding | 23.99M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 9.04% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 12.47.
| PE Ratio | 12.47 |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 12.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of -15.43.
| EV / Earnings | 47.87 |
| EV / Sales | 0.73 |
| EV / EBITDA | 9.76 |
| EV / EBIT | 18.30 |
| EV / FCF | -15.43 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 2.32.
| Current Ratio | 2.17 |
| Quick Ratio | 1.18 |
| Debt / Equity | 2.32 |
| Debt / EBITDA | 7.49 |
| Debt / FCF | -11.83 |
| Interest Coverage | 1.71 |
Financial Efficiency
Return on equity (ROE) is 6.53% and return on invested capital (ROIC) is 4.04%.
| Return on Equity (ROE) | 6.53% |
| Return on Assets (ROA) | 2.57% |
| Return on Invested Capital (ROIC) | 4.04% |
| Return on Capital Employed (ROCE) | 5.21% |
| Weighted Average Cost of Capital (WACC) | 4.38% |
| Revenue Per Employee | 330,461 |
| Profits Per Employee | 5,011 |
| Employee Count | 645 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 4.36 |
Taxes
In the past 12 months, Biokarpet has paid 877,917 in taxes.
| Income Tax | 877,917 |
| Effective Tax Rate | 21.16% |
Stock Price Statistics
The stock price has decreased by -3.45% in the last 52 weeks. The beta is 0.60, so Biokarpet's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -3.45% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 1.81 |
| Relative Strength Index (RSI) | 55.84 |
| Average Volume (20 Days) | 13,823 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biokarpet had revenue of EUR 213.15 million and earned 3.23 million in profits. Earnings per share was 0.13.
| Revenue | 213.15M |
| Gross Profit | 33.93M |
| Operating Income | 8.45M |
| Pretax Income | 4.15M |
| Net Income | 3.23M |
| EBITDA | 14.21M |
| EBIT | 8.45M |
| Earnings Per Share (EPS) | 0.13 |
Balance Sheet
The company has 5.06 million in cash and 118.65 million in debt, with a net cash position of -113.59 million or -4.74 per share.
| Cash & Cash Equivalents | 5.06M |
| Total Debt | 118.65M |
| Net Cash | -113.59M |
| Net Cash Per Share | -4.74 |
| Equity (Book Value) | 51.22M |
| Book Value Per Share | 2.10 |
| Working Capital | 51.48M |
Cash Flow
In the last 12 months, operating cash flow was 3.32 million and capital expenditures -13.34 million, giving a free cash flow of -10.03 million.
| Operating Cash Flow | 3.32M |
| Capital Expenditures | -13.34M |
| Depreciation & Amortization | 5.76M |
| Net Borrowing | 4.33M |
| Free Cash Flow | -10.03M |
| FCF Per Share | -0.42 |
Margins
Gross margin is 15.92%, with operating and profit margins of 3.97% and 1.52%.
| Gross Margin | 15.92% |
| Operating Margin | 3.97% |
| Pretax Margin | 1.95% |
| Profit Margin | 1.52% |
| EBITDA Margin | 6.67% |
| EBIT Margin | 3.97% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.19%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 1.19% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.19% |
| Earnings Yield | 8.02% |
| FCF Yield | -24.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 15, 2000. It was a forward split with a ratio of 2.
| Last Split Date | Mar 15, 2000 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Biokarpet has an Altman Z-Score of 1.5 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.5 |
| Piotroski F-Score | 8 |